Effect of metabolic reprogramming on the immune microenvironment in gastric cancer

Biomed Pharmacother. 2024 Jan:170:116030. doi: 10.1016/j.biopha.2023.116030. Epub 2023 Dec 20.

Abstract

Gastric cancer (GC) is a malignant tumor of the gastrointestinal tract with a high mortality rate worldwide, a low early detection rate and a poor prognosis. The rise of metabolomics has facilitated the early detection and treatment of GC. Metabolism in the GC tumor microenvironment (TME) mainly includes glucose metabolism, lipid metabolism and amino acid metabolism, which provide energy and nutrients for GC cell proliferation and migration. Abnormal tumor metabolism can influence tumor progression by regulating the functions of immune cells and immune molecules in the TME, thereby contributing to tumor immune escape. Thus, in this review, we summarize the impact of metabolism on the TME during GC progression. We also propose novel strategies to modulate antitumor immune responses by targeting metabolism.

Keywords: Cancer immunity; Gastric cancer; Immune microenvironment; Metabolism; TIME.

Publication types

  • Review

MeSH terms

  • Humans
  • Lipid Metabolism
  • Metabolic Reprogramming
  • Metabolomics
  • Neoplasms*
  • Stomach Neoplasms*
  • Tumor Microenvironment